Testosterone undecanoate 1mg
Products billed under this code include Aveed.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Aveed.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Aveed | Endo USA, Inc. | 67979-0511-43 | 750 | $1,652.25 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2.203 | +$0.054 | 1 MG | Testosterone undecanoate 1mg | v1, posted September 17, 2026 |
| 3Q26 | $2.149 | +$0.018 | 1 MG | Testosterone undecanoate 1mg | v1, posted September 15, 2026 |
| 2Q26 | $2.131 | +$0.062 | 1 MG | Testosterone undecanoate 1mg | v1, posted September 15, 2026 |
| 1Q26 | $2.069 | $0.00 | 1 MG | Testosterone undecanoate 1mg | v1, posted September 15, 2026 |
| 4Q25 | $2.069 | +$0.076 | 1 MG | Testosterone undecanoate 1mg | v1, posted September 8, 2026 |
| 3Q25 | $1.993 | −$0.029 | 1 MG | Testosterone undecanoate 1mg | v1, posted March 10, 2026 |
| 2Q25 | $2.022 | +$0.104 | 1 MG | Testosterone undecanoate 1mg | v1, posted March 10, 2026 |
| 1Q25 | $1.918 | −$0.028 | 1 MG | Testosterone undecanoate 1mg | v1, posted December 19, 2025 |
| 4Q24 | $1.946 | +$0.057 | 1 MG | Testosterone undecanoate 1mg | v1, posted June 11, 2025 |
| 3Q24 | $1.889 | −$0.037 | 1 MG | Testosterone undecanoate 1mg | v1, posted June 11, 2025 |
| 2Q24 | $1.926 | +$0.089 | 1 MG | Testosterone undecanoate 1mg | v1, posted March 11, 2025 |
| 1Q24 | $1.837 | +$0.102 | 1 MG | Testosterone undecanoate 1mg | v1, posted December 19, 2024 |
| 4Q23 | $1.735 | −$0.05 | 1 MG | Testosterone undecanoate 1mg | v1, posted October 10, 2024 |
| 3Q23 | $1.785 | −$0.06 | 1 MG | Testosterone undecanoate 1mg | v1, posted June 5, 2024 |
| 2Q23 | $1.845 | +$0.054 | 1 MG | Testosterone undecanoate 1mg | v1, posted February 23, 2024 |
| 1Q23 | $1.791 | −$0.025 | 1 MG | Testosterone undecanoate 1mg | v1, posted December 6, 2023 |
| 4Q22 | $1.816 | +$0.167 | 1 MG | Testosterone undecanoate 1mg | v1, posted June 22, 2023 |
| 3Q22 | $1.649 | −$0.01 | 1 MG | Testosterone undecanoate 1mg | v1, posted June 9, 2023 |
| 2Q22 | $1.659 | +$0.052 | 1 MG | Testosterone undecanoate 1mg | v1, posted December 14, 2022 |
| 1Q22 | $1.607 | −$0.023 | 1 MG | Testosterone undecanoate 1mg | v1, posted June 8, 2022 |
| 4Q21 | $1.63 | +$0.063 | 1 MG | Testosterone undecanoate 1mg | v1, posted June 2, 2022 |
| 3Q21 | $1.567 | −$0.022 | 1 MG | Testosterone undecanoate 1mg | v1, posted June 2, 2022 |
| 2Q21 | $1.589 | +$0.058 | 1 MG | Testosterone undecanoate 1mg | v1, posted March 1, 2022 |
| 1Q21 | $1.531 | – | 1 MG | Testosterone undecanoate 1mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.